Systemic a-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson's disease. (2021)
Attributed to:
Innovative Technologies for Stratified and Experimental Medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41380-019-0608-9
PubMed Identifier: 31758091
Publication URI: http://europepmc.org/abstract/MED/31758091
Type: Journal Article/Review
Volume: 26
Parent Publication: Molecular psychiatry
Issue: 2
ISSN: 1359-4184